Work

Tisagenlecleucel — the first approved CAR-T-cell therapy: implications for payers and policy makers

Year: 2017

Type: article

Source: Nature Reviews Clinical Oncology

DOI: 10.1038/nrclinonc.2017.156

Author: Vinay Prasad

Institutions: Oregon Health & Science University, OHSU Knight Cancer Institute

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2761202053

FWCI: 10.34

Cites: 5

Cited by: 237

Related to: 10